Clinical Report: Mum's the Word for Essilor

Overview

Essilor has collaborated with influencer mothers to share their children's experiences with Essilor® Stellest® lenses, which are designed to slow myopia progression. Positive feedback from parents highlights the lenses' effectiveness and the importance of raising awareness about myopia management.

Background

Myopia, or nearsightedness, is a growing public health concern, particularly among children. Effective management strategies are essential to slow its progression and prevent long-term vision impairment. Essilor® Stellest® lenses represent a clinically supported option for eye care practitioners to address this issue.

Data Highlights

No numerical data provided in the article.

Key Findings

• Essilor® Stellest® lenses have shown efficacy in slowing myopia progression in children.
• Influencer mothers reported positive outcomes, with one noting her daughter's eyesight remained stable after one year.
• Another parent described the lenses as 'game changing' for children at high risk of myopia.
• Essilor's collaboration with influencers aims to enhance awareness and foster discussions about myopia management.
• Clinical data supports the use of Stellest lenses as part of a comprehensive myopia management strategy.

Clinical Implications

Eye care practitioners should consider incorporating Essilor® Stellest® lenses into their myopia management plans, particularly for children at risk of progression. Engaging with parents through relatable narratives can enhance understanding and acceptance of myopia control options.

Conclusion

Essilor's initiative to share real-life experiences underscores the importance of effective communication in myopia management. The positive feedback from parents highlights the potential of Stellest lenses in improving children's eye health outcomes.

References

1. Eyecare Business, Eyecare Business, 2006 -- Last Word
2. Eyecare Business, Eyecare Business, 2026 -- Industry Intel Cure Blindness Project CooperVision SightGlass Vision and EssilorLuxottica
3. Eyecare Business, Eyecare Business, 2025 -- Retail Tech: EssilorLuxottica, Bausch & Lomb, ABB Optical Group
4. International Myopia Institute, 2023 -- Clinical Myopia Management Guidelines
5. JAMA Network, 2023 -- Spectacle Lenses With Aspherical Lenslets for Myopia Control vs Single-Vision Spectacle Lenses: A Randomized Clinical Trial
6. Eyecare Business — FYI
7. https://myopiainstitute.org/wp-content/uploads/2023/02/2023.02.12_IMI-Clinical-Myopia-Management-Guidelines_English.pdf
8. Spectacle Lenses With Aspherical Lenslets for Myopia Control vs Single-Vision Spectacle Lenses: A Randomized Clinical Trial | Trials | JAMA Ophthalmology | JAMA Network